Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2005
10/26/2005CN1688311A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
10/26/2005CN1688308A Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs
10/26/2005CN1688303A Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
10/26/2005CN1688300A Peritoneal dialysate containing taurine
10/26/2005CN1688267A Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition
10/26/2005CN1688193A Mixed compositions for controlling parasitic insects
10/26/2005CN1686556A Anti entity tumour medicinal composition containing blood vessel inhibitor
10/26/2005CN1686555A Anti entity tumour medicinal composition containing tetrazine kind compound
10/26/2005CN1686554A Anti entity tumour medicinal composition containing platinum compound
10/26/2005CN1686553A Anti entity tumour medicinal composition
10/26/2005CN1686552A Antientity tumour medicinal composition containing topoenzyme inhibitor
10/26/2005CN1686551A Anti entity tumour medicinal composition
10/26/2005CN1686550A Anti entity tumour medicinal composition containing dichloro ethamine kind drug
10/26/2005CN1686549A Medicinal composition for treating high blood pressure
10/26/2005CN1686548A Ulcer quieting medicine its preparation and use
10/26/2005CN1686547A Long time use compound preparation for treating diabetes
10/26/2005CN1686546A Anti entity tumour medicinal composition containing blood vessel inhibitor
10/26/2005CN1686545A Anti entity tumour medicinal composition
10/26/2005CN1686544A Anti entity tumour medicinal composition containing plant alkaloid
10/26/2005CN1224614C Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
10/26/2005CN1224598C Naphthalene derivatives
10/26/2005CN1224423C Pharmaceutical composition improved in peroral absorbability
10/26/2005CN1224420C Agent for treating visual cell function disorder
10/26/2005CN1224388C Modified prodrug forms of ap/amp
10/26/2005CN1224384C Dysuria remedies
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958351 NMDA NR2B antagonists for treatment
10/25/2005US6958336 Anticancer agents; immunosuppressants; antiallergens; antiinflammatory agents
10/25/2005US6958324 Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
10/25/2005US6958238 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof
10/25/2005US6958220 Inhibitors of proteasomal activity for stimulating hair growth
10/25/2005US6958160 liposomes include diacylglycerol-PEG compounds; melting point below about 40 degrees C, and acyl chains greater than or equal to 14 carbons in length; use in drug delivery, diagnostics, cosmetics, cosmeceuticals and nutraceuticals
10/25/2005CA2440764C Combination of brimonidine and timolol for topical ophthalmic use
10/25/2005CA2331053C Compositions and methods for treating conditions responsive to estrogen
10/25/2005CA2331009C Compositions and methods of treatment for conditions responsive to testosterone elevation
10/25/2005CA2329172C Storage stable extended release oral dosage composition comprising desloratadine and pseudoephedrine
10/25/2005CA2304657C Treatment of conduct disorder
10/25/2005CA2261725C Piperidine and piperazine derivatives and their use as muscarinic antagonists
10/21/2005CA2504582A1 Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer
10/21/2005CA2504401A1 Drug delivery systems for the prevention of neointimal hyperlasia
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097216A1 Compositions containing copper salts and soy products
10/20/2005WO2005097211A2 Compositions as adjuvants to improve immune responses to vaccines and methods of use
10/20/2005WO2005097204A1 Preventives/remedies for cancer
10/20/2005WO2005097193A2 Sequential sprm/progestin treatment
10/20/2005WO2005097192A2 Active substance combination of a carbinol compound and an opioid
10/20/2005WO2005097190A2 Systems and methods for providing a stem cell bank
10/20/2005WO2005097189A1 Carcinoma cell-specific apoptosis inducing agent targeting gene relevant to chromosome stabilization
10/20/2005WO2005097146A2 Dairy components effective for fat loss
10/20/2005WO2005097138A2 Combinations comprising oxcarbazepine to treat affective disorders
10/20/2005WO2005097121A1 Angiogenesis-affecting compounds and methods of use thereof
10/20/2005WO2005097119A2 Pten inhibitors
10/20/2005WO2005097107A2 Diphenyl - indol-2-on compounds and their use in the treatment of cancer
10/20/2005WO2005097099A1 Active substance combination comprising a carbinol combined to at least an nsaid
10/20/2005WO2005097088A2 Inhibition of nuclear export as a treatment for cardiac hypertrophy and heart failure
10/20/2005WO2005097087A2 Merged ion channel modulating compounds and uses thereof
10/20/2005WO2005097086A2 Use of 5,10-methylene tetrahydrofolate for the treatment of cancer
10/20/2005WO2005097085A1 Nutrient system for individualized responsive dosing regimens
10/20/2005WO2005097081A1 Ion binding polymers and uses thereof
10/20/2005WO2005097072A1 Ion binding compositions
10/20/2005WO2005096846A1 Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
10/20/2005WO2005096840A1 Kiwifruit extracts and extraction methods
10/20/2005WO2005075484A3 Chemokine ccr5 receptor modulators
10/20/2005WO2005072268A3 Treatment of degeneraative cartilage conditions in a mammal with glycosidase inhibitors
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005WO2005035525A3 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease
10/20/2005WO2005020923A3 Composition and method for the treatment of cancer and other physiologic conditions based on modulation of the ppar-gamma pathway and her-kinase axis
10/20/2005WO2004064785A3 Cancer therapy sensitizer
10/20/2005WO2003002094A8 Enhanced pharmacokinetic profile of hydrophobic substances
10/20/2005WO2002097033A3 Antibodies that immunospecifically bind to trail receptors
10/20/2005US20050235374 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
10/20/2005US20050235367 Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof
10/20/2005US20050235365 Helicokinin-receptor from insects
10/20/2005US20050234245 Estrogen receptor modulators
10/20/2005US20050234227 Ribosome structure and protein synthesis inhibitors
10/20/2005US20050234225 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression
10/20/2005US20050234134 Betamimetics with a prolonged duration of activity, processes for preparing them, and their use as pharmaceutical compositions
10/20/2005US20050234129 Salts of nateglinide
10/20/2005US20050234126 Amide derivatives as inhibitors of the enzymatic activity of renin
10/20/2005US20050234124 Carboxyalkylether-ACAT inhibitor combinations
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234089 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
10/20/2005US20050234083 Diamino-pyrimidines and their use as angiogenesis inhibitors
10/20/2005US20050234080 Mitotic kinesin inhibitors
10/20/2005US20050234075 Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
10/20/2005US20050234060 Pyrrolotriazine kinase inhibitors
10/20/2005US20050234043 ACE inhibitor-vasopressin antagonist combinations
10/20/2005US20050234028 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol
10/20/2005US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
10/20/2005US20050234013 comprising a heparinoid, a local anesthetic agent and a buffering compound
10/20/2005US20050234011 Re-epithelializing pharmaceutical compositions comprising xanthan gum
10/20/2005US20050234008 Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050234001 Methods and compositions for modulating gluconeogenesis using PGC-1
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233992 Regeneration of endogeneous myocardial tissue by induction of neovascularization
10/20/2005US20050233991 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
10/20/2005US20050233989 Flavin N-oxides: new anti-cancer agents and pathogen eradication agents
1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 1151